An artificial neural networking model for the prediction of post‐hepatectomy survival of patients with early hepatocellular carcinoma

This study aimed to establish a prognostic artificial neural network model (ANN) for early hepatocellular carcinoma (HCC) following partial hepatectomy.

[1]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[2]  V. Wong,et al.  High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Matthew Zeidenberg,et al.  Neural networks in artificial intelligence , 1990, Ellis Horwood series in artificial intelligence.

[4]  Y. Shiratori,et al.  Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention , 2001, Expert review of anticancer therapy.

[5]  M. Choti,et al.  Predictors of Survival After Resection of Early Hepatocellular Carcinoma , 2009, Annals of surgery.

[6]  Geoffrey E. Hinton,et al.  Learning internal representations by error propagation , 1986 .

[7]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[8]  D M Rodvold,et al.  Neural network and regression predictions of 5‐year survival after colon carcinoma treatment , 2001, Cancer.

[9]  U. Ghoshal,et al.  Predicting mortality in patients with cirrhosis of liver with application of neural network technology , 2003, Journal of gastroenterology and hepatology.

[10]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[11]  M. Makuuchi,et al.  IHPBA concordant classification of primary liver cancer: working group report. , 2003, Journal of hepato-biliary-pancreatic surgery.

[12]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[13]  Kui Wang,et al.  Overexpression of aspartyl‐(asparaginyl)‐β‐hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome , 2010, Hepatology.

[14]  S. Kawasaki,et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.

[15]  D M Rodvold,et al.  Artificial neural networks in clinical urology. , 1999, Urology.

[16]  Guido Schwarzer,et al.  Artificial neural networks for diagnosis and prognosis in prostate cancer. , 2002, Seminars in urologic oncology.

[17]  Marco Vivarelli,et al.  Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors , 2006, European journal of gastroenterology & hepatology.

[18]  F. Piscaglia,et al.  Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. , 2010, Journal of hepatology.

[19]  M. Makuuchi,et al.  Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan , 2000, Hepatology.

[20]  Surveillance algorithm and diagnostic algorithm for hepatocellular carcinoma , 2010 .

[21]  H. Nomura,et al.  Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  Yutaka Matsuyama,et al.  Staging of Hepatocellular Carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM Systems in a Cohort of 13,772 Patients in Japan , 2007, Annals of surgery.

[23]  M. Sherman,et al.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis , 2001, Gut.

[24]  H. Ueno,et al.  Treatment strategy for small hepatocellular carcinoma: Comparison of long‐term results after percutaneous ethanol injection therapy and surgical resection , 2001, Hepatology.

[25]  G. Klintmalm.  Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. , 1998, Annals of surgery.

[26]  L. Ellis,et al.  Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[28]  J. Hanley.  Receiver operating characteristic (ROC) methodology: the state of the art. , 1989, Critical reviews in diagnostic imaging.

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  G. Gores,et al.  Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy , 2000, Hepatology.

[31]  M. Makuuchi,et al.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. , 1999, Archives of surgery.

[32]  O. Seror,et al.  Local/regional and systemic treatments of hepatocellular carcinoma. , 2005, Seminars in liver disease.

[33]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[34]  M. Omata,et al.  Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review , 2008, Hepatology international.

[35]  M. Makuuchi,et al.  Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan † , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[36]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[37]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[38]  Patrick van der Smagt,et al.  Introduction to neural networks , 1995, The Lancet.

[39]  K. Shiraki,et al.  A clinical study of lectin‐reactive alpha‐fetoprotein as an early indicator of hepatocellular carcinoma in the follow‐up of cirrhotic patients , 1995, Hepatology.

[40]  N D Heaton,et al.  Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease , 2006, Gut.

[41]  J. Marrero,et al.  Current approaches to the treatment of early hepatocellular carcinoma. , 2010, The oncologist.